Lv0
0 积分 2022-05-10 加入
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
2小时前
待确认
Diffuse Infiltrating Oligodendroglioma and Astrocytoma
23小时前
已完结
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
4个月前
已完结
The molecular blueprint of targeted radionuclide therapy
4个月前
已完结
Updated Clinical practice guidelines for the management of adult diffuse gliomas
4个月前
已完结
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
4个月前
已完结
Glioma
4个月前
已完结
Dissecting the clinicopathologic, genomic, and prognostic significance of anaplastic lymphoma kinase rearrangement in resected lung adenocarcinoma
4个月前
已完结
Perioperative Therapy in Early-Stage Lung Cancer
6个月前
已完结
皖公网安备34019202002308
